London: Experts have urged the UK’s National Health Service (NHS) to prepare for a future where Alzheimer’s might be treatable.
Leading researchers suggest that the introduction of new drugs to slow Alzheimer’s could significantly improve treatment outcomes for patients and potentially lead to the eradication of the disease.
While these Alzheimer’s-slowing treatments received a green light in the UK, the NHS rejected them for specific reasons.
Dr. John Hardy from the UK Dementia Research Institute stated that drugs like Lecanemab and Donanemab, among others, show that we can alter the course of the disease.
This is why researchers are very excited. Although I don’t want to criticize the NHS too harshly, we need to lobby the government to organize the institution better so that patients can benefit from these treatments.